SCHEMBL24619098

SCHEMBL24619098

CC(C)(O)c1ccnc2c(F)cc(-c3nc(NC4CCN(C=O)CC4)ncc3F)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCND3 P30281 15/20 0.49
▸ CDK6 Q00534 15/20 0.49
▸ CDK4 P11802 15/20 0.49
▸ CCND1 P24385 15/20 0.49
▸ CDK1 P06493 4/20 0.41
▸ CCNB1 P14635 4/20 0.41
▸ CCNE1 P24864 4/20 0.41
▸ CDK2 P24941 4/20 0.41
▸ CCNB2 O95067 1/20 0.41
▸ CCNE2 O96020 1/20 0.41
▸ CDK5 Q00535 1/20 0.41
▸ CDK5R1 Q15078 1/20 0.41
▸ CCNB3 Q8WWL7 1/20 0.41
▸ MAPK3 P27361 1/20 0.40
▸ MAPK1 P28482 2/20 0.37
▸ CCNT1 O60563 1/20 0.35
▸ CDK7 P50613 1/20 0.35
▸ CDK9 P50750 1/20 0.35
▸ CCNH P51946 1/20 0.35
▸ MNAT1 P51948 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29727232 0.88 CDK2 (0.56) CCND3CDK6CDK4CCND1CDK1
SCHEMBL24619627 0.88 CDK2 (0.56) CCND3CDK6CDK4CCND1CDK1
SCHEMBL29727049 0.87 CDK6 (0.49) CCND3CDK6CDK4CCND1CDK1
SCHEMBL24619338 0.87 CDK6 (0.49) CCND3CDK6CDK4CCND1CDK1
SCHEMBL29199711 0.85 CDK4 (0.51) CCND3CDK6CDK4CCND1CDK1
SCHEMBL30915280 0.85 CDK6 (0.46) CCND3CDK6CDK4CCND1CDK1
SCHEMBL29727268 0.79 CDK2 (0.56) CCND3CDK6CDK4CCND1CDK1
SCHEMBL29727182 0.79 CDK6 (0.47) CCND3CDK6CDK4CCND1CDK1
SCHEMBL29727277 0.78 CDK6 (0.46) CCND3CDK6CDK4CCND1CDK1
SCHEMBL24619097 0.77 CCNE1 (0.58) CCND3CDK6CDK4CCND1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022149057-A1 CDK INHIBITORS RHIZEN PHARMACEUTICALS AG (CH) 2022-07-14 — — WO disclosed
Send feedback